Yidu suffers from lingering Covid chill
The medical data company’s revenue tumbled 55% in the six months through March as hospitals and other medical institutions delayed their resumption of non-Covid services Key Takeaways: Yidu Tech’s revenue…
2158.HK
Recent Articles
RELATED ARTICLES
-
Yidu finds good medicine in regulatory nod for its AI
2158.HK
- BenQ files for IPO as business looks stable, but with few growth spots
- Tong Ren Tang Healthcare IPO banks on famous name, growth through M&A
- Bayzed joins IPO quest as medical rivalry heats up
-
So-Young dolls up with pivot to high-end services
SY.US
-
Chaoju Eye Care sees strong growth in acquisitions
2219.HK
- Margins ring alarm bells as 160 Health readies IPO
Discover hidden China stock gems in our weekly newsletter